Using Calcitonin Gene-related Peptide Monoclonal Antibodies for Migraine Headache Treatment and Prevention
Asian Journal of Research and Reports in Neurology · pp. 46–53 · Published 14 Nov 2019
Abstract
Novel drugs are available now for treating and preventing migraine attacks. Those new drugs have a special strategy to treat migraine by modifying the signaling of calcitonin gene- related peptide (CGRP) which is a strong neuropeptide released from the nerves. Monoclonal antibodies (mAbs) have been developed for targeting the CGRP pathway by binding the CGRP ligand (eptinezumab, galcanezumab fremanezumab,) or the CGRP receptor (erenumab). Recent studies show that mAbs have several advantages over small molecule antagonists, including high selectivity and reduced potential for drug–drug interactions. In this article we reviewed literature to assess whether mABs can be used for treatment of acute and chronic migraine safely compared to classical antimigraine agents.
Cited by 0
No indexed citations yet.
Related research
- Pattern of Hearing Impairment in a Tertiary Institution in Ado Ekiti, Nigeria — shares topic coverage
- Weight Gain as Tuberculosis Treatment Regimen Progresses in Patients Receiving Antituberculosis Therapy — shares topic coverage
- TREAT-B has Good Accuracy in Selecting HBV Infected Patients for Treatment in Sudan — shares topic coverage
- Botox Treatment: A Comprehensive Review — shares topic coverage
- Harnessing Artificial Intelligence in Healthcare Analytics: From Diagnosis to Treatment Optimization — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.